Some time ago a poor poster posted that they were suffering from Melanoma: I wondered if thi smight hep him or her.
Paw Paw was also given $5million grant for further research and although when the research was completed,no pappers were published on the magnificent results achieved for some patients.
I am a Sar shareholder myself and am in no way being negative about the company but thought I would bring this little piece of important information, regarding Paw Paw, to one or two people who may benefit.
Still here. All rested and just waiting for news on the completion of both sets of pre-clinical work. It shouldn't be too long now IMO. And if / when trials start it will get a lot more interesting (well, it couldn't get quieter!)
Mine, too. MCAP of SAR now lower of the two. Great potential for both, but I know which I expect to increase the most in the remainder of this year. Still SAR might easily surprise us with unexpected news.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.